Herbalife
229 hedge funds and large institutions have $5.34B invested in Herbalife in 2020 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 93 reducing their positions, and 19 closing their positions.
100% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 19
9% more funds holding
Funds holding: 211 → 229 (+18)
0.93% less ownership
Funds ownership: 87.81% → 86.88% (-0.93%)
8% less capital invested
Capital invested by funds: $5.84B → $5.34B (-$494M)
18% less call options, than puts
Call options by funds: $68.1M | Put options by funds: $83.1M
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
35% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 93
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$69.2M |
| 2 |
Goldman Sachs
New York
|
+$55.2M |
| 3 |
Morgan Stanley
New York
|
+$54.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.2M |
Top Sellers
HLF Hedge Fund Activity: Q3 2020 in Review
229 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Herbalife (HLF) for Q3 2020, worth a combined $5.34B — down 8.5% from $5.84B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new HLF positions and 19 closed out — a net gain of 19 holders — while 60 added to existing stakes and 93 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $69.2M. The largest seller was Icahn Carl, cutting an estimated $723M.
- 229 institutional investors held Herbalife (HLF) as of Q3 2020, up from 211 in Q2 2020.
- Funds reported $5.34B of Herbalife stock for Q3 2020, down 8.5% quarter-over-quarter.
- 38 funds opened new Herbalife positions in Q3 2020 and 19 closed out, a net change of +19 holders.
- The largest Herbalife buyer in Q3 2020 was D.E. Shaw & Co, an estimated $69.2M added.
- The largest Herbalife seller in Q3 2020 was Icahn Carl, an estimated $723M sold.
Based on aggregated 13F filings for Q3 2020.